Strategy of leukocyte filtration for immunomodulation: development of stainless steel leukocyte filter.
暂无分享,去创建一个
[1] M. Kazatchkine,et al. Methods for assessing monocytic cytokine production as an index of biocompatibility. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] C. Dinarello,et al. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. , 1991, The Journal of biological chemistry.
[3] W. Bell,et al. Depletion of white cells from platelet concentrates with a new adsorption filter , 1989, Transfusion.
[4] G. Andreu,et al. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. , 1988, Blood.
[5] L. R. Hill,et al. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. , 1988, Blood.
[6] C. Hannum,et al. Interleukin-1 inhibitors. , 1987, Annales de l'Institut Pasteur. Immunology.
[7] J. Dayer,et al. Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). , 1986, The Journal of clinical investigation.
[8] P. Morris,et al. Alloimmunisation to HLA Antigens following Transfusion with Leucocyte‐Poor and Purified Platelet Suspensions , 1985, Vox sanguinis.